FITC Anti-Human CD279/PD-1 Antibody[EH12.2H7]

Introducing the FITC Anti-Human CD279/PD-1 Antibody [EH12.2H7], a cutting-edge immunological tool designed to facilitate advanced research in the field of human immunology. This antibody, conjugated with FITC, offers exceptional specificity and sensitivity in detecting and quantifying the programmed cell death protein 1 (PD-1) receptor on human cells.

The FITC Anti-Human CD279/PD-1 Antibody [EH12.2H7] is meticulously engineered using state-of-the-art techniques, ensuring its high affinity and reliability. Its exceptional binding capacity to the PD-1 receptor enables precise identification and characterization of PD-1-expressing cells, thereby contributing to a deeper understanding of immune responses and immunotherapy development.

This antibody's conjugation with FITC, a widely utilized fluorochrome, allows for straightforward and efficient flow cytometry analysis. The bright fluorescence emitted by FITC facilitates the discrimination and isolation of PD-1-positive cells, enabling researchers to explore their functional properties and interactions within the immune system.

With its exceptional performance and versatility, the FITC Anti-Human CD279/PD-1 Antibody [EH12.2H7] is an indispensable tool for immunologists, researchers, and scientists engaged in the investigation of human immune responses, cancer immunotherapy, and autoimmune diseases. Its reliable and reproducible results empower researchers to make significant strides in unraveling the complexities of immune regulation and developing novel therapeutic strategies.

Choose the FITC Anti-Human CD279/PD-1 Antibody [EH12.2H7] to unlock new insights into the intricate mechanisms governing human immune responses. Experience the pinnacle of immunological research with this cutting-edge antibody, meticulously crafted to elevate your scientific endeavors.